This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Event: 2276

Key Event Title

A descriptive phrase which defines a discrete biological change that can be measured. More help

Increased, protein expression of proprotein convertase subtilisin/kexin type 9 (PCSK9)

Short name

The KE short name should be a reasonable abbreviation of the KE title and is used in labelling this object throughout the AOP-Wiki. More help

Increased, PCSK9 protein expression

Explore in a Third Party Tool

Biological Context

Structured terms, selected from a drop-down menu, are used to identify the level of biological organization for each KE. More help

Level of Biological Organization
Cellular

Cell term

The location/biological environment in which the event takes place.The biological context describes the location/biological environment in which the event takes place. For molecular/cellular events this would include the cellular context (if known), organ context, and species/life stage/sex for which the event is relevant. For tissue/organ events cellular context is not applicable. For individual/population events, the organ context is not applicable. Further information on Event Components and Biological Context may be viewed on the attached pdf. More help

Cell term
eukaryotic cell

Organ term

Key Event Components

The KE, as defined by a set structured ontology terms consisting of a biological process, object, and action with each term originating from one of 14 biological ontologies (Ives, et al., 2017; https://aopwiki.org/info_pages/2/info_linked_pages/7#List). Biological process describes dynamics of the underlying biological system (e.g., receptor signalling).Biological process describes dynamics of the underlying biological system (e.g., receptor signaling). The biological object is the subject of the perturbation (e.g., a specific biological receptor that is activated or inhibited). Action represents the direction of perturbation of this system (generally increased or decreased; e.g., ‘decreased’ in the case of a receptor that is inhibited to indicate a decrease in the signaling by that receptor). Note that when editing Event Components, clicking an existing Event Component from the Suggestions menu will autopopulate these fields, along with their source ID and description. To clear any fields before submitting the event component, use the 'Clear process,' 'Clear object,' or 'Clear action' buttons. If a desired term does not exist, a new term request may be made via Term Requests. Event components may not be edited; to edit an event component, remove the existing event component and create a new one using the terms that you wish to add. Further information on Event Components and Biological Context may be viewed on the attached pdf. More help

Process	Object	Action
increased circulating total protein level	proprotein convertase subtilisin/kexin type 9	increased

Key Event Overview

AOPs Including This Key Event

All of the AOPs that are linked to this KE will automatically be listed in this subsection. This table can be particularly useful for derivation of AOP networks including the KE.Clicking on the name of the AOP will bring you to the individual page for that AOP. More help

AOP Name	Role of event in AOP	Point of Contact	Author Status	OECD Status
Activation, Pregnane-X receptor leads to increased plasma LDL cholesterol via PCSK9	KeyEvent	John Frisch (send email)	Under development: Not open for comment. Do not cite

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KE.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available in relation to this KE. More help

Term	Scientific Term	Evidence	Link
mammals	mammals	High	NCBI

Life Stages

An indication of the the relevant life stage(s) for this KE. More help

Life stage	Evidence
All life stages	Moderate

Sex Applicability

An indication of the the relevant sex for this KE. More help

Term	Evidence
Unspecific	High

Key Event Description

A description of the biological state being observed or measured, the biological compartment in which it is measured, and its general role in the biology should be provided. More help

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is primarily expressed in the liver (Seidah et al. 2014). PCSK9 has an important role in lipid uptake regulation. Sterol Regulatory Element Binding Proteins (SREBPs) regulate transcription rates, increasing protein expression of proprotein convertase subtilisin/kexin type 9 (PCSK9; Lambert et al. 2006; Seidah et al. 2014). Proprotein convertase subtilisin/kexin type 9 is also referred to as Neural Apoptosis-Regulated Convertase-1 (NARC-1; Horton et al. 2003; Benjannet et al. 2004). PCSK9 binds to low density lipoprotein receptor (LDLR) on the surface of liver cells, resulting in the degradation of LDLR and decreased uptake of cholesterol (Poirier et al. 2008; Seidah et al. 2014).

How It Is Measured or Detected

A description of the type(s) of measurements that can be employed to evaluate the KE and the relative level of scientific confidence in those measurements.These can range from citation of specific validated test guidelines, citation of specific methods published in the peer reviewed literature, or outlines of a general protocol or approach (e.g., a protein may be measured by ELISA). Do not provide detailed protocols. More help

Real time PCR can be used to measure PCSK9 transcript abundance, which is an indirect – and only semi-quantitative indicator of PCSK9 protein abundance. PCSK9 protein can be measured via Western blotting or enzyme immunoassay.

Domain of Applicability

A description of the scientific basis for the indicated domains of applicability and the WoE calls (if provided). More help

Life Stage: All life stages.

Sex: Applies to both males and females.

Taxonomic: Primarily studied in humans and laboratory rodents.

References

List of the literature that was cited for this KE description. More help

Benjannet, S., Rhainds, D., Essalmani, R., Mayne, J., Wickham, L., Jin, W., Asselin, M.-C., Hemelin, J., Varret, M., Allrd, D., Trillard, M., Abifadel, M., Tebon, T., Attie, A.D., Rader, D.J., Boileau, C., Brissette, L., Chretien, M., Prat, A., and Seidah, N.G. 2004. NARC-1/PCSK9 and its natural mutants: Zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. The Journal of Biological Chemistry. 279(47): 48865–48875.

Horton, J.D., Shah, N.A., Warrington, J.A., Anderson, N.N., Park, S.W., Brown, M.S., and Goldstein, J.L. 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proceedings of the National Academy of Sciences 100(21): 12027–12032.

Lambert, G., Jarnoux, A.-J., Pineau, T., Pape, O., Chetiveaux, M., Laboisse, C., Krempf, M., and Costet, P. 2006. Fasting induces hyperlipidemia in mice overexpressing Proprotein Convertase Subtilisin Kexin Type 9: Lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor. Endocrinology 147(10): 4985–4995.

Poirier, S., Mayer, G., Benjannet, S., Bergeron, E., Marcinkiewicz, J., Nassoury, N., Mayer, H., Nimpf, J., Prat, A., and Seidah, N.G. 2008. The Proprotein Convertase PCSK9 induces the degradation of Low Density Lipoprotein Receptor (LDLR) and Its closest family members VLDLR and ApoER2. The Journal of Biological Chemistry 283(4): 2363-2372.

Seidah, N.G., Awan, Z., Chretien, M., and Mbikay, M. 2014. PCSK9: A key modulator of cardiovascular health. Circulation Research 114(6): 1022-1036.

NOTE: Italics indicate edits from John Frisch November 2024.